Ellipses Pharma Report issue

For profit Phase 2
Founded: London United Kingdom (2015)

Organization Overview

First Clinical Trial
2020
NCT04581512
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ellipses Pharma | james@ellipses.life